SynthesisJournal of global health2025
Barriers and enablers to centre-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease in low- and middle-income countries: a systematic review.
Synthesis in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Access to pulmonary rehabilitation in real-world territorial care: the APTA friendly network as a structural and organizational model.BMC health services research · 2026Article
- Loneliness in Chronic Obstructive Pulmonary Disease: A Multidimensional Determinant of Clinical Outcomes and Disease Management.Journal of clinical medicine · 2026Review
- Knowledge, attitudes, and practices related to pulmonary rehabilitation and associated influencing factors among older adults with chronic obstructive pulmonary disease in a county medical community.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and morbidity in low- and middle-income countries (LMICs). Despite the proven benefits of pulmonary rehabilitation (PR) for patients with COPD, its referral, uptake, and completion rates remain low. This systematic review aimed to identify the barriers and enablers to centre-based PR among patients with COPD in LMICs. Methods: We searched PubMed, Web of Science, Cumulative Index to Nursing and Allied Health Literature, and Scopus databases from their inception to September 2023 and updated in May 2025. Studies involving patients with COPD, their caregivers, and healthcare professionals (HCPs), were included if they reported barriers or enablers to centre-based PR in LMICs. Data were extracted based on the socio-ecological model of health behaviour, and a narrative synthesis was conducted. Results: Five articles met the inclusion criteria, comprising four quantitative and one qualitative study, involving 1544 patients with COPD, 11 caregivers, and 84 HCPs, which were conducted in Iran, China, Colombia, and Brazil. The most frequently identified barrier to PR was personal financial constraints. Other frequently reported barriers included symptom severity of COPD, lack of family and social support, inadequate competency of HCPs, and logistical challenges. Enablers to PR included higher proficiency of HCP, higher personal and family income, higher educational levels, better patient awareness of PR, and awareness programmes. Conclusions: Barriers and enablers to PR referral, uptake, and completion in LMICs were identified at multiple levels: intrapersonal, interpersonal, organisational, community, and policy. Some factors were common to both LMICs and high-income countries, such as frequency of hospitalisation, social support, HCP knowledge and skills, logistical challenges, and awareness programmes, but personal financial constraints were a unique barrier to LMICs. To improve existing PR services or to effectively implement new PR programmes, these factors need to be considered. Registration: PROSPERO: CRD42024528467.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.